Topical Drug Bioavailability, Bioequivalence, and Penetration

<p>.- 1 Percutaneous Absorption</p><p> </p><p>.- 2 Animal Models for Percutaneous Absorption</p><p> </p><p>.- 3 Mitigating Dermal Exposure to Agrochemicals</p><p> </p><p>.- 4 Importance of In Vitro Drug Release</p><p> </p><p>.- 5 Diffusion Cell Design                        </p><p> </p><p>.- 6 In Vitro Product Quality Tests and Product Performance Tests for Topical and Transdermal Drug Products</p><p> </p><p>.- 7 Safety and efficacy testing of topical products; Practical considerations</p><p> </p><p>.- 8 Challenges in Evaluating Bioequivalence of Topical Dermatological Drug Products </p><p> </p><p>.- 9 Methods for the Assessment of Bioequivalence of Topical Dosage Forms: Correlations, Optimization Strategies and Innovative Approaches </p><p> </p><p>.- 10 Application of Microdialysis in Assessing Cutaneous Bioavailability </p><p> </p><p>.- 11 Follicular Drug Penetration</p><p> </p><p>.- 12 Development of Pilosebaceous Unit-Targeted Drug Products</p><p> </p><p>.- 13 Deep Percutaneous Penetration into Muscles and Joints: Update</p><p> </p><p>.- 14 Efficacy &amp; Toxicity of Microneedle based devices</p><p> </p><p>.- 15 Mathematical Models for Topical and Transdermal Drug Products</p><p> </p><p>.- 16 Transdermal Patches: An Industrial Perspective on the Relevance of in vitro Skin Permeation Studies and Approaches on Design of Manufacturing Processes</p><p> </p><p>.- 17 Transdermal Drug Delivery Systems.  Regulatory Considerations:  NDA and ANDA Requirements</p><p> </p><p>.- 18 Transdermal Estradiol and Testosterone Transfer in Man: Existence, Models, and Strategies for Prevention </p><p> </p><p>.- 19 Effects of occlusion on dermal drug delivery: implications for bioequivalence measurement</p><p> </p><p>.- 20 Challenges with Clinical Endpoints – Bioequivalence</p><p> </p><p>.- 21 Clinical Considerations of Bioequivalence For Topical Dermatologic Drugs</p><p> </p><p>.- 22 OECD Test Guideline 428 – A method for in vitro percutaneous absorption measurement?</p><p> </p><p>.- 23 Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products: Current Challenges and Future Prospects.</p>